ARTICLE | Company News
OncoVista Inc., OSI deal
December 10, 2007 8:00 AM UTC
OSIP granted AVUG an exclusive, worldwide license to OSI-7904L. The liposomal formulation of a thymidylate synthase inhibitor has completed Phase II testing in gastric/gastroesophageal junction cance...